biotech

Origen To Produce Therapeutics in Genetically Engineered Chickens

Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Food and Agriculture , Genomics, Proteomics and Bioinformatics , Stem Cells on June 9, 2006

Origen To Produce Therapeutics in Genetically Engineered Chickens
Spurred by European regulators' approval of the production of an anti-clotting agent in transgenic goats, other firms are tailgating. California-based Origen Therapeutics have been developing genetically modified chickens to manufacture human antibodies and other proteins.
"We now have a technology to genetically modify chickens in a very precise way," Robert Kay, the president of Origen, said in an interview.

He said the technology would allow scientists to alter the chicken genome in ways that could allow them to produce drugs in very large quantities and develop new therapies.

The technology is based on genetically engineering primordial germ cells, the precursor cells to sperm and eggs, in chickens.

Aside from genetically engineering chickens to serve as a production plant for therapeutics, Origen is also working on genetically enhacing chickens to grow bigger, and faster.

Read more from the Reuters report: New technique to create genetically modified chickens.

Permalink: Origen To Produce Therapeutics in Genetically Engineered Chickens

Tags: GMO  genomics  genetically  biotech  therapeutics  genetically+engineered  therapeutics+genetically  origen 

Vote for Origen To Produce Therapeutics in Genetically Engineered Chickens:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 2 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells